je.st
news
Tag: fda approves
FDA Approves Mercks KEYTRUDA (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy
2016-08-06 01:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab), the companys anti-PD-1 (programmed death receptor-1) therapy, at a fixed dose of 200 mg every three weeks, for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orInvestor:Teri Loxam, 908-740-1898orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
FDA approves use of folic acid in corn masa flour
2016-04-15 01:00:00| Food Processing Technology
The US Food and Drug Administration (FDA) has approved folic acid to be added to corn masa flour.
FDA approves 1st cheaper version of J&J's top drug Remicade
2016-04-06 02:53:09| Biotech - Topix.net
" Federal health officials have approved a cheaper version of Johnson & Johnson's blockbuster drug, Remicade, a pricey biotech medicine for inflammatory diseases. The approval of Inflectra Tuesday is only the second time that the Food and Drug Administration has approved a quasi-generic biotech drug for the U.S. market.
UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma
2016-03-23 21:16:09| Biotech - Topix.net
The U.S. Food and Drug Administration said on Wednesday it had approved Teva Pharmaceutical Industries Ltd's drug to treat asthma in adults who have a history of severe attacks despite taking medication. The drug, Cinqair, part of a new wave of biotech drugs for severe asthma, is administered intravenously every four weeks in combination with other drugs.
Tags: update
drug
severe
biotech
FDA approves powered robotic exoskeleton for clinical and personal use
2016-03-14 16:00:12| Extremetech
They're calling it a "Segway with legs," and it can help paraplegics walk again. While it can't restore sensation, devices like the Indego exoskeleton could be an important component in helping individuals with spinal cord injuries regain their mobility.
Tags: use
powered
personal
clinical
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »